BREAST CANCER AWARENESS

MYRIAD GENETICS PRESENTS

CLICK ON A DAY TO VIEW A FACT

BREAST CANCER AWARENESS

OCTOBER DAILY AWARENESS

SUN MON TUE WED THUR FRI SAT

2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30 31

1

tweet this

OCTOBER 1

1 in 8 women will develop breast cancer in their lifetime.1

1 in 8

tweet this

OCTOBER 2

Breast cancer is the 2nd leading cause of cancer-related deaths among women. The American Cancer Society estimates 40,290 women will die from breast cancer in the U.S. in 2015.2

40,290 cancer-related deaths

tweet this

OCTOBER 3

Know what breast cancer can look and feel like.2,3

Symptoms of breast cancer can include lumps or thickening of skin in the breast or underarm areas; changes in the shape of the breast; dimpling; puckering; scaly, red or swollen skin on any area of the breast; an inverted (turned inward) nipple; or leakage of fluid (especially blood) from the nipple.

A mass or lump, which may feel as

small as a pea.

A change in the size, shape, or contour of the

breast.

A blood-stained or clear fluid

discharge from the nipple.

A change in shape or

position of the nipple.

tweet this

OCTOBER 4

Five to 10% of breast cancers are due to a hereditary (inherited) cause.2 The most comon hereditary causes of breast cancer are mutations in the BRCA1 and BRCA2 genes. Hear about one patient’s journey with hereditary breast cancer.

tweet this

OCTOBER 5

Are you at risk for hereditary breast cancer?

Know the red flags associated with Hereditary Cancer.

tweet this

OCTOBER 6

Breast cancer does not only affect women.

It is estimated that 2,350 men will be diagnosed with breast cancer in the U.S. in 2015.4

Although breast cancer in men is rare, an estimated 2,350 men will be diagnosed with breast cancer

tweet this

OCTOBER 7

Check your breasts for lumps. 8 out of 10 lumps are discovered by women themselves.5

Be aware of how your breasts normally look and feel and report any changes to a health professional.

A mass or lump, which may feel as small as a pea.

tweet this

OCTOBER 8

BRCA positive women who have had breast cancer ALSO have up to a 12.7% risk for ovarian cancer to develop within 10 years of their breast cancer diagnosis. Knowing this allows BRCA+ women to TAKE ACTION to help reduce the likelihood of ovarian cancer, following breast cancer diagnosis.6

tweet this

OCTOBER 9

Women of Ashkenazi Jewish heritage are at higher risk of having BRCA mutation. The U.S. Preventive Services Task Force recommends testing for BRCA mutations for Ashkenazi Jewish women if they have a first-degree relative with breast or ovarian cancer or two second-degree relatives on the same side of the family with breast or ovarian cancer.7

tweet this

OCTOBER 10

In addition to BRCA1 and BRCA2, other genes can increase the risk for breast cancer. Learn more about these genes here.

BREAST

BRCA1/2

PALB2

CHEK2

NBNBPIP1

TPS3

BARD1

STK11 PTEN

ATM

CDH1

tweet this

OCTOBER 11

Risk factors for breast cancer include: A mutation in a hereditary breast cancer gene, personal or family history of breast cancer, obesity, exposure to estrogen and progesterone (combined hormone therapy) after menopause, excessive alcohol use, among others.8

tweet this

OCTOBER 12

Women with the BRCA1 genetic mutation can have up to an 87% risk of developing breast cancer by age 70 (compared to the average woman’s risk of 12.3% to age 80).9

87%risk of developing breast cancer by 70

tweet this

OCTOBER 13

Medical guidelines recommend those at general-population risk for breast cancer have regular screening. Beginning in their 20s, these include: clinical breast exams every 1-3 years, and self-awareness of breast changes. Beginning at ages 40-50 these include: annual clinical breast exams, annual mammograms, self-awareness of breast changes.10

For those at increased risk (e.g., >20% lifetime risk of breast cancer), the following screening changes may be warranted: clinical breast exams every 6-12 months, annual mammograms and MRIs beginning 10 years prior to the youngest age of diagnosis in the family but not less than age 30, breast awareness, and consideration of other risk reduction strategies.10

Individuals with greater breast cancer risk may require a more intensive medical management plan after consultation with your health care professional.

tweet this

OCTOBER 14

Women at increased risk for breast cancer have risk-reducing options – such as risk-reducing medications (like tamoxifen and raloxifene) and risk-reducing surgeries (for example double mastectomy with reconstruction). These options should be discussed with a medical professional and considered based on a number of factors including personal history, family history and/or the identification of a gene mutation.11

tweet this

OCTOBER 15

A family history of breast cancer is also important for men to know.

Not only could a hereditary breast cancer syndrome impact their female relatives, but men with certain genetic mutations are also at increased risk for cancers of the prostate, pancreas and melanoma. Hear John’s journey after being diagnosed with Hereditary Breast and Ovarian Cancer Syndrome.

tweet this

OCTOBER 16

TODAY IS NATIONAL MAMMOGRAM DAY!

tweet this

OCTOBER 17

Mammography has helped reduce breast cancer in the U.S. by ~ 1/3 since 1990.12

reducing breast cancer by 1/3 since 1990

tweet this

OCTOBER 18

If you’ve been diagnosed with breast cancer, you’re up to four times more likely to develop a new cancer in the same breast or in the other breast.13

tweet this

OCTOBER 19

A woman’s risk of breast cancer approximately doubles if she has a first-degree relative (mother, sister, daughter) who has been diagnosed with breast cancer.14

tweet this

OCTOBER 20

Knowing your personal and family cancer history can help your doctor prevent breast cancer or detect it at an earlier stage. Hear about how knowing her cancer family history helped Marissa prevent cancer.

tweet this

OCTOBER 21

Chemotherapy can be given before or after surgery for breast cancer. Most of the time it is given after surgery, which is called adjuvant chemotherapy. However, sometimes it is given before surgery and is known as neoadjuvant chemotherapy.15

tweet this

OCTOBER 22

There are many advocacy organizations that provide a community of support for women at all different stages of a breast cancer diagnosis or those who are finished with treatment and living their “new normal.” Click here for a list of resource that will empower patients and their families with information.

tweet this

OCTOBER 23

Targeted therapy is a novel way to treat breast cancer and is different than standard chemotherapy. These types of treatment target specific genetic changes in the cancer cells and generally cause different (and frequently less severe) side effects.16

tweet this

OCTOBER 24

The first targeted therapy developed for breast cancer was Herceptin. It was approved for use in breast cancer by the FDA in 1998. Herceptin targets overexpression of the Her2 gene.17

The National Comprehensive Cancer Network (NCCN) recommends that all breast tumors be tested for Her2 status as part of the standard clinical workup.18

tweet this

OCTOBER 25

In some cases, a double mastectomy can lower the chance of developing breast cancer to less than 10%.19

Read about Angelina Jolie-Pitt’s choice to have a risk-reducing double mastectomy after learning that she was positive for the BRCA1 gene mutation.

tweet this

OCTOBER 26

Triple negative breast cancer (TNBC) accounts for about 15-20% of all breast cancers.20, 21 Some breast cancers test negative for two hormone (estrogen and progesterone) receptors and HER2 (a growth-promoting protein). These breast cancers are called triple negative breast cancer (TNBC).22

Testing negative for these three markers means commonly used hormone therapy and targeted drugs are typically not successful in treating these cancers. Chemotherapy may still be helpful. Women diagnosed with triple negative breast cancer before age 60 should be evaluated further for genetic risk.23

tweet this

OCTOBER 27

Patients with Triple Negative Breast Cancer (TNBC) and a BRCA mutation may frequently benefit from the addition of a platinum-based chemotherapy drug.24

tweet this

OCTOBER 28

Take the quiz to learn about your risk for hereditary breast cancer.

tweet this

OCTOBER 29

Companion diagnostic tests help physicians identify which patients are most likely to benefit from a particular drug.

In cancer, these tests can help physicians chose the best chemotherapy treatment for your individual tumor.25

tweet this

OCTOBER 30

If you have breast cancer and are BRCA positive, you may be eligible for a clinical trial investigating targeted therapy with a new class of drugs called PARP inhibitors. Discuss this option with your health care provider.

tweet this

View full interactive calendar here.

OCTOBER 31

Knowledge is power – talk to your doctor today about your personal or family history of breast cancer. Find a health care professional here.